Submission of Notice of 39th Annual General Meeting of the Company to be held August 27, 2026.

August 3, 2026 To To Listing Department, The Corporate Relations Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED Exchange Plaza, Phiroz Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street, MUMBAI -400 051 MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804 Dear Sir/Madam Sub: Notice of 39th Annual General Meeting Further to our letter dated July 29, 2026 intimating the date of 39th Annual General Meeting (AGM) of the Members of the Company and pursuant to Regulation 34 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, please find enclosed the Notice of 39th AGM of the Company to be held on Thursday, August 27, 2026 at 3:30 p.m. IST through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM") which is being sent to the shareholders of the Company through electronic mode. Please take the information on record. Thanking you, Yours faithfully, For AUROBINDO PHARMA LIMITED B. Adi Reddy Company Secretary Encl.: as above Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 , Telangana, India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com AUROBINDO PHARMA LIMITED (CIN - L24239TG1986PLC015190) Regd. Office: Plot No.2, Maithrivihar, Ameerpet, Hyderabad – 500 038, Telangana, India. Tel No.: +91 40 2373 6370, Fax No.: +91 40 2374 1080 Corp. Office: Galaxy, Floors 22-24 Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Hyderabad – 500 032, Telangana, India. Tel No.: +91 40 66725000 / 66721200, Fax No.: +91 40 67074044 E-mail: info@aurobindo.com; Website: www.aurobindo.com NOTICE NOTICE is hereby given that the 39th Annual General 3. To confirm the interim dividend of `4 per equity Meeting of the Members of Aurobindo Pharma Limited share of `1 as dividend paid for the financial will be held on Thursday, the 27th day of August 2026 year 2025-26 and in this regard, to consider and if at 3:30 p.m. (IST) through Video Conferencing (“VC”) thought fit, to pass the following resolution as an / Other Audio-Visual Means (“OAVM”) to transact the Ordinary Resolution: following business: " RESOLVED THAT the interim dividend of `4.00 per equity share of `1, paid for the financial year ORDINARY BUSINESS 2025-26 as declared by the Board of Directors of the 1. To receive, consider and adopt the Audited Company be and is hereby confirmed and approved Standalone Financial Statements of the Company as dividend for the financial year 2025-26.” for the financial year ended March 31, 2026, and the reports of the Board of Directors and Statutory 4. To appoint a Director in place of Mr. K. Nithyananda Reddy (DIN:01284195) who retires by rotation at this Auditor thereon and in this regard, to consider and Annual General Meeting and being eligible, seeks if thought fit, to pass the following resolution as an re-appointment and in this regard, to consider and Ordinary Resolution: if thought fit, to pass the following resolution as an Ordinary Resolution: “ RESOLVED THAT the audited standalone financial statement of the Company for the financial year “ RESOLVED THAT in accordance with the ended March 31, 2026 and the reports of the provisions of Section 152 and other applicable provisions of the Companies Act, 2013, Mr. K. Board of Directors and Statutory Auditor thereon, Nithyananda Reddy (DIN:01284195), who retires as circulated to the members, be and are hereby by rotation at this meeting, be and is hereby considered and adopted.” reappointed as a Director of the Company, liable to retire by rotation.” 2. To receive, consider and adopt the Audited Consolidated Financial Statements of the Company 5. To appoint a Director in place of Dr. M. Madan for the financial year ended March 31, 2026, and Mohan Reddy (DIN: 01284266) who retires by the report of Statutory Auditor thereon and in this rotation at this Annual General Meeting and being eligible, seeks re-appointment and in this regard, regard, to consider and if thought fit, to pass the to consider and if thought fit, to pass the following following resolution as an Ordinary Resolution: resolution as an Ordinary Resolution: “ RESOLVED THAT the audited consolidated financial “ RESOLVED THAT in accordance with the statement of the Company for the financial year provisions of Section 152 and other applicable ended March 31, 2026 and the report of Statutory provisions of the Companies Act, 2013, Dr. M. Auditor thereon, as circulated to the members, be Madan Mohan Reddy (DIN: 01284266), who retires and are hereby considered and adopted.” by rotation at this meeting, be and is hereby reappointed as a Director of the Company, liable to retire by rotation.” SPECIAL BUSINESS No. 5360) as Secretarial Auditor of the Company for a period of 5 (Five) consecutive years from the 6. T o appoint the Secretarial Auditor of the financial year 2026-27 till the financial year 2030- Company and in this regard, to consider and 31 at such remuneration and on such terms and if thought fit, to pass the following resolution conditions as may be mutually agreed between as an Ordinary Resolution: the Board of Directors of the Company and the “ RESOLVED THAT pursuant to the provisions Secretarial Auditor. of Section 204 and other applicable provisions, if any, of the Companies Act, 2013 and the F URTHER RESOLVED THAT the Board of Directors Companies (Appointment and Remuneration be and is hereby authorised to do all such acts, of Managerial Personnel) Rules 2014 (including deeds, matters and things as may be necessary, any statutory modification(s) or re-enactment expedient or incidental for the purpose of giving thereof, for the time being in force), read with effect to this resolution and to settle any question or difficulty in connection herewith and incidental Regulation 24A of the Securities and Exchange hereto.” Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, as amended By Order of the Board of Directors from time to time, pursuant to recommendation of Aurobindo Pharma Limited of the Board of Directors, consent of the members of the Company be and is hereby accorded for appointment of M/s. RPR & Associates, B. Adi Reddy Practicing Company Secretaries, Hyderabad (a Place: Hyderabad Company Secretary peer reviewed firm, represented by Mr. Y. Ravi Date : May 21, 2026 Membership No. ACS 13709 Prasada Reddy, Proprietor of the firm having CP. NOTES 3. Institutional/Corporate Members (i.e. other than individuals/ HUFs, NRIs, etc.,) are required to send 1. Pursuant to the General Circular No. 14/2020 dated a scanned copy (PDF/JPG Format) of its Board or April 8, 2020 and subsequent circulars issued in this Governing Body Resolution / Authorization etc., regard, the latest being General Circular No. 3/2025 authorising its representative to attend the AGM dated September 22, 2025, issued by the Ministry through VC / OAVM on its behalf and cast it’s votes of Corporate Affairs (MCA) and the Circulars issued through e-voting. The said Resolution / Authorization from time to time by the Securities Exchange Board shall be sent to the Scrutinizer by email through of India (hereinafter collectively referred to as “the its registered email address to rprassociateshyd@ Circulars”) companies are allowed to hold Annual gmail.com with a copy marked to evoting@kfintech. General Meetings (AGM) through VC/OAVM, com. without the physical presence of the members at a common venue and also to send the copies of 4. The Explanatory Statement setting out all material annual report in electronic mode to those members facts pursuant to Section 102 of the Act with respect whose email addresses are registered with the to the Special Bu [Showing first 8,000 characters — download PDF for full document]